TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -50.35% |
| Q3 2025 | 31.94% |
| Q2 2025 | 19.02% |
| Q1 2025 | 11.39% |
| Q4 2024 | -29.86% |
| Q3 2024 | -9.58% |
| Q2 2024 | -20.33% |
| Q1 2024 | -23.33% |
| Q4 2023 | -19.64% |
| Q3 2023 | 38.05% |
| Q2 2023 | 22.05% |
| Q1 2023 | -9.97% |
| Q4 2022 | 30.35% |
| Q3 2022 | -12.84% |
| Q2 2022 | 15.71% |
| Q1 2022 | 9.06% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |